Drug intelligence / Profile preview

boswellia + UC-II

Development stage
Unknown
Lead developer
Doctor's Best
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

Boswellia + UC-II is a **combination dietary supplement** containing Boswellia serrata extract and undenatured type II collagen (UC-II). Both ingredients are known for supporting joint health and mobility. **Boswellia serrata** contains boswellic acids that inhibit pro-inflammatory enzymes (notably 5-lipoxygenase), thereby reducing leukotriene-mediated inflammation in joints. **UC-II (undenatured type II collagen)** is derived from chicken sternum cartilage and works via *oral tolerance*: it interacts with Peyer’s patches in the gut, inducing the generation of regulatory T cells and subsequent secretion of anti-inflammatory cytokines (e.g., TGF-beta, IL-4, IL-10), modulating immune responses to joint collagen. The combination has demonstrated efficacy in improving mobility and reducing pain and stiffness in humans and dogs with osteoarthritis, with no significant adverse effects reported in trials[1][2][3][6][7][8].

Brand names
Doctor's Best Boswellia with UC-II
Other names
boswellia with UC-IIboswellia serrata + UC-IIboswellia + undenatured type II collagen
02

Targets

MRP2 (Canalicular multispecific organic anion transporter 1)ABCB1 (P-glycoprotein)TOP (DNA topoisomerases)SLCO1B3 (Organic anion transporting polypeptide 1B3)15-LOX (Lysyl Oxidase)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)PGHS-1 (Prostaglandin G/H Synthase 1)Cyp (Cyclophilin family)

Beyond the preview

Go deeper on boswellia + UC-II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on boswellia + UC-II.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call